Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pregnancy-Induced | 8 | 2025 | 76 | 3.480 |
Why?
|
| Postpartum Period | 13 | 2025 | 235 | 2.580 |
Why?
|
| Pre-Eclampsia | 5 | 2023 | 223 | 2.320 |
Why?
|
| Cardiovascular Diseases | 6 | 2024 | 2082 | 1.680 |
Why?
|
| Diabetes, Gestational | 3 | 2024 | 111 | 1.480 |
Why?
|
| Myocardial Ischemia | 3 | 2024 | 310 | 1.450 |
Why?
|
| Heart Arrest | 3 | 2024 | 380 | 1.290 |
Why?
|
| Pregnancy Complications | 4 | 2025 | 547 | 1.210 |
Why?
|
| Cardiomyopathies | 2 | 2023 | 516 | 1.100 |
Why?
|
| Pregnancy | 18 | 2025 | 7576 | 0.910 |
Why?
|
| Hemodynamic Monitoring | 1 | 2023 | 16 | 0.800 |
Why?
|
| Puerperal Disorders | 1 | 2023 | 51 | 0.780 |
Why?
|
| Vein of Galen Malformations | 1 | 2022 | 15 | 0.760 |
Why?
|
| Cerebral Veins | 1 | 2022 | 22 | 0.750 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 51 | 0.750 |
Why?
|
| Cerebrovascular Disorders | 1 | 2023 | 114 | 0.740 |
Why?
|
| Metabolic Syndrome | 2 | 2022 | 363 | 0.710 |
Why?
|
| Heart Failure | 3 | 2024 | 2307 | 0.690 |
Why?
|
| Embolization, Therapeutic | 1 | 2022 | 225 | 0.630 |
Why?
|
| Stroke | 1 | 2023 | 1049 | 0.440 |
Why?
|
| Maine | 5 | 2025 | 11 | 0.430 |
Why?
|
| Stillbirth | 2 | 2024 | 103 | 0.370 |
Why?
|
| Female | 19 | 2025 | 71214 | 0.350 |
Why?
|
| Risk Factors | 6 | 2024 | 10961 | 0.320 |
Why?
|
| Rural Population | 3 | 2025 | 260 | 0.280 |
Why?
|
| Humans | 20 | 2025 | 131759 | 0.250 |
Why?
|
| Contraception | 2 | 2024 | 62 | 0.250 |
Why?
|
| Mastitis | 1 | 2025 | 4 | 0.240 |
Why?
|
| Antihypertensive Agents | 2 | 2025 | 422 | 0.230 |
Why?
|
| Lactation | 1 | 2025 | 197 | 0.210 |
Why?
|
| Depression | 2 | 2023 | 1352 | 0.210 |
Why?
|
| Prospective Studies | 3 | 2025 | 6507 | 0.210 |
Why?
|
| Breast Feeding | 1 | 2025 | 234 | 0.200 |
Why?
|
| Gonorrhea | 1 | 2023 | 42 | 0.200 |
Why?
|
| Chlamydia Infections | 1 | 2023 | 53 | 0.200 |
Why?
|
| Cardiac Output | 1 | 2023 | 152 | 0.190 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 1518 | 0.190 |
Why?
|
| Vascular Resistance | 1 | 2023 | 182 | 0.190 |
Why?
|
| Medication Adherence | 1 | 2025 | 334 | 0.180 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2025 | 505 | 0.180 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2022 | 60 | 0.180 |
Why?
|
| Ambulatory Care | 1 | 2025 | 407 | 0.170 |
Why?
|
| Monitoring, Physiologic | 1 | 2023 | 371 | 0.170 |
Why?
|
| Adult | 8 | 2025 | 31700 | 0.170 |
Why?
|
| Proportional Hazards Models | 1 | 2024 | 1405 | 0.160 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2024 | 481 | 0.160 |
Why?
|
| Infant, Newborn | 2 | 2023 | 8594 | 0.150 |
Why?
|
| Cohort Studies | 3 | 2025 | 5122 | 0.150 |
Why?
|
| Mental Health | 1 | 2023 | 384 | 0.150 |
Why?
|
| Premature Birth | 1 | 2022 | 414 | 0.130 |
Why?
|
| Infant, Premature | 1 | 2022 | 857 | 0.120 |
Why?
|
| Pandemics | 1 | 2023 | 1165 | 0.120 |
Why?
|
| Hospitalization | 1 | 2023 | 1942 | 0.110 |
Why?
|
| Young Adult | 5 | 2025 | 10099 | 0.100 |
Why?
|
| United States | 4 | 2024 | 11812 | 0.070 |
Why?
|
| Adolescent | 4 | 2025 | 20987 | 0.060 |
Why?
|
| Minnesota | 1 | 2025 | 181 | 0.060 |
Why?
|
| Parity | 1 | 2025 | 84 | 0.060 |
Why?
|
| Maternal Age | 1 | 2025 | 137 | 0.060 |
Why?
|
| Birth Intervals | 1 | 2024 | 3 | 0.050 |
Why?
|
| Insurance Claim Review | 1 | 2024 | 25 | 0.050 |
Why?
|
| Insurance Coverage | 1 | 2025 | 117 | 0.050 |
Why?
|
| Chlamydia trachomatis | 1 | 2023 | 30 | 0.050 |
Why?
|
| Contraceptive Agents | 1 | 2023 | 13 | 0.050 |
Why?
|
| Sexual Partners | 1 | 2023 | 82 | 0.050 |
Why?
|
| Contact Tracing | 1 | 2023 | 58 | 0.050 |
Why?
|
| Prenatal Care | 1 | 2025 | 346 | 0.050 |
Why?
|
| California | 1 | 2022 | 128 | 0.050 |
Why?
|
| Counseling | 1 | 2023 | 237 | 0.040 |
Why?
|
| Urban Population | 1 | 2023 | 281 | 0.040 |
Why?
|
| Risk | 1 | 2022 | 739 | 0.040 |
Why?
|
| Recurrence | 1 | 2024 | 1483 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2023 | 17662 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 455 | 0.040 |
Why?
|
| Middle Aged | 3 | 2025 | 28892 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2024 | 500 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2022 | 898 | 0.040 |
Why?
|
| Vaccination | 1 | 2024 | 1044 | 0.040 |
Why?
|
| Incidence | 1 | 2025 | 3349 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2022 | 1224 | 0.030 |
Why?
|
| Patient Safety | 1 | 2022 | 444 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2024 | 3451 | 0.030 |
Why?
|
| Disease Progression | 1 | 2023 | 2221 | 0.030 |
Why?
|
| Prevalence | 1 | 2022 | 2695 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2022 | 3696 | 0.020 |
Why?
|
ACKERMAN-BANKS's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(85)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_